France
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 22.77 M
|
Dec. 31, 2023 | USD 1.88 | -0.49% |
|
France |
|
2 |
USD 2.47 M
|
Dec. 31, 2023 | USD 3.40 | -0.30% |
|
France |
|
3 |
USD 188.74 K
|
Dec. 31, 2023 | USD 1.82 | 1.18% |
|
France |
|
4 |
USD -34.61 K
|
Dec. 31, 2023 | USD 4.25 | 1.59% |
|
France |
|
5 |
USD -97.13 K
|
Dec. 31, 2023 | USD 2.16 | 6.70% |
|
France |
|
6 |
USD -143.49 K
|
Dec. 31, 2023 | USD 1.29 | -1.75% |
|
France |
|
7 |
USD -152.32 K
|
Dec. 31, 2023 | USD 6.08 | 1.81% |
|
France |
|
8 |
USD -203.09 K
|
Dec. 31, 2023 | USD 1.42 | -0.83% |
|
France |
|
9 |
USD -275.94 K
|
Dec. 31, 2023 | USD 1.50 | -9.33% |
|
France |
|
10 |
USD -350.99 K
|
Dec. 31, 2023 | USD 26.07 | 0.60% |
|
France |
|
11 |
USD -385.21 K
|
Dec. 31, 2023 | USD 3.05 | 0.95% |
|
France |
|
12 |
USD -485.65 K
|
Dec. 31, 2023 | USD 8.53 | 3.61% |
|
France |
|
13 |
USD -559.60 K
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
14 |
USD -601.81 K
|
Dec. 31, 2023 | USD 1.53 | 0.60% |
|
France |
|
15 |
USD -661.39 K
|
March 31, 2024 | USD 16.86 | 0.98% |
|
France |
|
16 |
USD -808.00 K
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
17 |
USD -1.45 M
|
Dec. 31, 2023 | USD 2.05 | -2.81% |
|
France |
|
18 |
USD -2.21 M
|
Dec. 31, 2023 | USD 3.97 | 0.60% |
|
France |
|
19 |
USD -2.91 M
|
Dec. 31, 2023 | USD 2.22 | -0.32% |
|
France |
|
20 |
USD -3.40 M
|
Dec. 31, 2023 | USD 1.95 | -2.23% |
|
France |
|
21 |
USD -4.79 M
|
Dec. 31, 2023 | USD 2.02 | -2.42% |
|
France |
|
22 |
USD -6.88 M
|
June 30, 2024 | USD 5.46 | 0.23% |
|
France |
|
23 |
USD -8.53 M
|
Dec. 31, 2023 | USD 2.29 | 4.37% |
|
France |
|
24 |
USD -8.93 M
|
Dec. 31, 2023 | USD 6.25 | -0.54% |
|
France |
|
25 |
USD -12.23 M
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
|
26 |
USD -15.51 M
|
June 30, 2024 | USD 3.36 | -0.01% |
|
France |
|
27 |
USD -15.51 M
|
Dec. 31, 2023 | USD 1.74 | -2.29% |
|
France |
|
28 |
USD -17.32 M
|
Dec. 31, 2023 | USD 23.70 | 2.39% |
|
France |
|
29 |
USD -17.73 M
|
Dec. 31, 2023 | USD 0.68 | -1.49% |
|
France |
|
30 |
USD -20.84 M
|
Dec. 31, 2023 | USD 71.52 | -1.80% |
|
France |
|
31 |
USD -22.72 M
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
32 |
USD -24.71 M
|
Dec. 31, 2023 | USD 6.44 | -3.56% |
|
France |
|
33 |
USD -25.30 M
|
Dec. 31, 2023 | USD 27.83 | 2.50% |
|
France |
|
34 |
USD -46.94 M
|
June 30, 2024 | USD 23.39 | -1.14% |
|
France |
|
35 |
USD -50.94 M
|
Dec. 31, 2023 | USD 10.08 | 4.45% |
|
France |
|
36 |
USD -55.77 M
|
Dec. 31, 2023 | USD 39.47 | -3.91% |
|
France |
|
37 |
USD -60.50 M
|
Dec. 31, 2023 | USD 2.27 | 11.78% |
|
France |
|
38 |
USD -66.15 M
|
Dec. 31, 2023 | USD 27.36 | -1.07% |
|
France |
|
39 |
USD -83.11 M
|
Dec. 31, 2023 | USD 13.50 | -2.38% |
|
France |
|
40 |
USD -151.54 M
|
Dec. 31, 2023 | USD 3.26 | 2.55% |
|
France |
|
41 |
USD -194.08 M
|
June 30, 2024 | USD 12.99 | 0.21% |
|
France |
|
42 |
USD -351.18 M
|
Dec. 31, 2023 | USD 5.49 | 1.56% |
|
France |
|
43 |
USD -539.51 M
|
Dec. 31, 2023 | USD 110.89 | -1.59% |
|
France |
|
44 |
USD -738.98 M
|
Dec. 31, 2023 | USD 1.91 | 0.06% |
|
France |
|
45 |
USD -1.18 B
|
Dec. 31, 2023 | USD 122.64 | 0.35% |
|
France |
|
46 |
USD -3.01 B
|
Dec. 31, 2023 | USD 208.18 | -0.28% |
|
France |
|
47 |
USD -6.84 B
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
The Health Care company in France with the highest Net Cash Used For Investing Activities is Innate Pharma S.A. (Paris Stock Exchange: IPH.PA) at USD 22.77 M.
The Health Care company in France with the lowest Net Cash Used For Investing Activities is Sanofi (Paris Stock Exchange: SAN.PA) at USD -6.84 B.
The top 10 Health Care companies in France by Net Cash Used For Investing Activities are Innate Pharma S.A., Genfit S.A., PHAXIAM Therapeutics S.A., Predilife S.A., Aelis Farma SA, ABIONYX Pharma SA, Adocia SA, Affluent Medical SA, Valbiotis SA and Eurobio Scientific Société anonyme.
The bottom 10 Health Care companies in France by Net Cash Used For Investing Activities are Sanofi, Sartorius Stedim Biotech S.A., Ipsen S.A., Clariane SE, bioMérieux S.A., EMEIS, Ramsay Générale de Santé SA, Euroapi S.A., Cegedim SA and Guerbet SA.